SCHEMBL6718079

SCHEMBL6718079

CCOC(=O)C(C)(Cc1ccc(OCCOC2CCCCO2)cc1)Oc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 17/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
PPARG P37231 13/20 0.50
PPARD Q03181 9/20 0.50
OPRK1 P41145 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6714812 0.90 KMT2A (0.48) PPARAMEN1KMT2APPARGPPARD
SCHEMBL6715028 0.83 MEN1 (0.48) PPARAMEN1KMT2APPARGPPARD
SCHEMBL6715187 0.81 MEN1 (0.50) PPARAMEN1KMT2APPARGPPARD
SCHEMBL6714958 0.80 MEN1 (0.51) PPARAMEN1KMT2APPARGPPARD
SCHEMBL6712986 0.80 MEN1 (0.51) PPARAMEN1KMT2APPARGPPARD
SCHEMBL6714997 0.80 PPARA (0.58) PPARAPPARGPPARDOPRK1
SCHEMBL6713621 0.79 PPARA (0.57) PPARAPPARGPPARDOPRK1
SCHEMBL3998978 0.78 PPARA (0.56) PPARAPPARGPPARDOPRK1
SCHEMBL6722312 0.77 PPARA (0.54) PPARAPPARGPPARDOPRK1
SCHEMBL3806558 0.77 MEN1 (0.61) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 US disclosed
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US disclosed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 PPARA 71/4885MEN1 3916/4885KMT2A 3611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.